Skip to main content

Table 2 LYG, Total costs and ICER for PCV13, PCV10 and no vaccination in Colombian children younger than 5 years, 2014

From: Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia

 

No vaccine

PCV10

PCV13

Total discounted LYG

0

18 708

25 396

Discounted medical costs avoided

0

$ - 13 703 271

$ - 19 479 395

Vaccine costs*

0

$ 28 920 564

$ 31 904 432

Total costs

0

$ 15 217 293

$ 12 425 037

C/E Prevented cases (per additional LYG)

 

$ 813.41

$ 489.26

Incremental analysis

   

ICER No Vaccine vs. PCV10

$ 813.41

  

ICER PCV10 vs. PCV13

$ - 417.53

  
  1. *Included administration costs.
  2. LYG: Life Years Gained.
  3. C/E: Cost-effectiveness ratio.